Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 6Phase 1/2 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 44Lymphoid 39Myeloid 17Breast 14Plasma cell 13Gynecologic 12Genitourinary 11Sarcoma 10CNS 7Classical hematology 4Head & Neck 3Dermatologic 3Thoracic 2Gastrointestinal 2Endocrine 1

Conditions

Pancreatic Neoplasms 2Rectal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Gemcitabine 153Oxaliplatin 124Fluorouracil 108Capecitabine 105pembrolizumab 92Bevacizumab 79Leucovorin 76Irinotecan 72Nivolumab 70130-nm albumin-bound paclitaxel 68Paclitaxel 62Cisplatin 62Cetuximab 60Cyclophosphamide 47Albumin-Bound Paclitaxel 45Radiotherapy 39Docetaxel 36durvalumab 33Sorafenib 32Taxes 29Carboplatin 27fludarabine 26tislelizumab 25Drug Therapy 25atezolizumab 23Folfox protocol 23regorafenib 20lenvatinib 19Ipilimumab 19sintilimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Filgrastim × Gastrointestinal × Clear all
NCT01858883 2019-07-18

Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors

Incyte Corporation

Phase 1/2 Completed
55 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00004087 2011-06-22

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer

Garden State Cancer Center at the Center for Molecular Medicine and Immunology

Phase 1/2 Completed
15 enrolled
Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡